These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 8634448)

  • 1. Elevation of cerebrospinal fluid soluble CD27 levels in patients with meningeal localization of lymphoid malignancies.
    Kersten MJ; Evers LM; Dellemijn PL; van den Berg H; Portegies P; Hintzen RQ; van Lier RA; von dem Borne AE; van Oers RH
    Blood; 1996 Mar; 87(5):1985-9. PubMed ID: 8634448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levels of serum and cerebrospinal fluid soluble CD27 in the diagnosis of leptomeningeal involvement of hematolymphoid malignancies.
    Kara IO; Sahin B; Gunesacar R
    Adv Ther; 2007; 24(4):741-7. PubMed ID: 17901023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic utility of CSF soluble CD27 for primary central nervous system lymphoma in immunocompetent patients.
    Murase S; Saio M; Andoh H; Takenaka K; Shinoda J; Nishimura Y; Sakai N; Takami T
    Neurol Res; 2000 Jul; 22(5):434-42. PubMed ID: 10935213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid soluble CD27 levels in children with non-Hodgkin lymphomas.
    Yalçin B; Canpinar H; Kutluk MT; Varan A; Akyüz C; Büyükpamukçu M
    Pediatr Hematol Oncol; 2004 Dec; 21(8):717-23. PubMed ID: 15739627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of elevated levels of soluble factors in the cerebrospinal fluid in patients with adult T-cell leukemia.
    Uozumi K; Ishitsuka K; Ohno N; Nakahara K; Utsunomiya A; Hanada S; Arima T
    Leuk Lymphoma; 1995 Nov; 19(5-6):437-45. PubMed ID: 8590844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased levels of soluble CD27 in the cerebrospinal fluid are not diagnostic for leptomeningeal involvement by lymphoid malignancies.
    van den Bent MJ; Lamers CH; van 't Veer MB; Sillevis Smitt PA; Bolhuis RL; Gratama JW
    Ann Hematol; 2002 Apr; 81(4):187-91. PubMed ID: 11976819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased levels of CSF soluble CD27 in patients with primary central nervous system lymphoma.
    Murase S; Saio M; Takenaka K; Shinoda J; Nishimura Y; Sakai N; Takami T
    Cancer Lett; 1998 Oct; 132(1-2):181-6. PubMed ID: 10397472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid neopterin levels in children with central nervous system leukemia.
    Millot F; Dhondt JL; Mazingue F; Mechinaud F; Auget JL; Bauters F; Harousseau JL
    Leuk Lymphoma; 1993 Mar; 9(4-5):351-6. PubMed ID: 8348070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble CD27 Levels in Cerebrospinal Fluid as a Prognostic Biomarker in Clinically Isolated Syndrome.
    van der Vuurst de Vries RM; Mescheriakova JY; Runia TF; Jafari N; Siepman TA; Hintzen RQ
    JAMA Neurol; 2017 Mar; 74(3):286-292. PubMed ID: 28055081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant expression of CD27 and soluble CD27 (sCD27) in HIV infection and in AIDS-associated lymphoma.
    Widney D; Gundapp G; Said JW; van der Meijden M; Bonavida B; Demidem A; Trevisan C; Taylor J; Detels R; Martínez-Maza O
    Clin Immunol; 1999 Nov; 93(2):114-23. PubMed ID: 10527687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical significance of soluble interleukin-2 receptor levels in the cerebrospinal fluid in patients with adult T-cell leukemia complicated with meningeal infiltration].
    Tanaka K; Shiraishi K; Sakamoto A; Okubo Y; Fukuda Y; Fukahori S; Jojima H; Osabe S; Honda J; Natori H; Oizumi K
    Gan To Kagaku Ryoho; 1996 Jun; 23(7):863-9. PubMed ID: 8678534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and release of CD27 in human B-cell malignancies.
    van Oers MH; Pals ST; Evers LM; van der Schoot CE; Koopman G; Bonfrer JM; Hintzen RQ; von dem Borne AE; van Lier RA
    Blood; 1993 Dec; 82(11):3430-6. PubMed ID: 8241510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Humoral CSF parameters in the differential diagnosis of hematologic CNS neoplasia.
    Weller M; Stevens A; Sommer N; Schabet M; Wiethölter H
    Acta Neurol Scand; 1992 Aug; 86(2):129-33. PubMed ID: 1414221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum soluble CD27, but not thymidine kinase, is an independent prognostic factor for outcome in indolent non-Hodgkin's lymphoma.
    Kok M; Bonfrer JM; Korse CM; de Jong D; Kersten MJ
    Tumour Biol; 2003; 24(1):53-60. PubMed ID: 12743427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of Central Nervous System (CNS) Involvement in Children With Non-Hodgkin's Lymphoma (NHL) and the Diagnostic Value of CSF Flow Cytometry in CNS Positive Disease.
    Huang S; Jin L; Yang J; Duan Y; Zhang M; Zhou C; Zhang YH
    Technol Cancer Res Treat; 2021; 20():15330338211016372. PubMed ID: 34060372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid concentrations of soluble CD27 in HTLV-I associated myelopathy and multiple sclerosis.
    Hintzen RQ; Paty D; Oger J
    J Neurol Neurosurg Psychiatry; 1999 Jun; 66(6):791-3. PubMed ID: 10329758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid beta-2-microglobulin in adult patients with acute leukemia or lymphoma: a useful marker in early diagnosis and monitoring of CNS-involvement.
    Hansen PB; Kjeldsen L; Dalhoff K; Olesen B
    Acta Neurol Scand; 1992 Mar; 85(3):224-7. PubMed ID: 1575009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble TACI and soluble BCMA as biomarkers in primary central nervous system lymphoma.
    Thaler FS; Laurent SA; Huber M; Mulazzani M; Dreyling M; Ködel U; Kümpfel T; Straube A; Meinl E; von Baumgarten L
    Neuro Oncol; 2017 Nov; 19(12):1618-1627. PubMed ID: 28521029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of sCD27 in the cerebrospinal fluid identifies patients with neuroinflammatory disease.
    Feresiadou A; Nilsson K; Ingelsson M; Press R; Kmezic I; Nygren I; Svenningsson A; Niemelä V; Gordh T; Cunningham J; Kultima K; Larsson A; Burman J
    J Neuroimmunol; 2019 Jul; 332():31-36. PubMed ID: 30928869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of central nervous system involvement in patients with leukemia or non-Hodgkin's lymphoma by immunological marker analysis of cerebrospinal fluid cells.
    Hooijkaas H; Adriaansen HJ; van Dongen JJ
    Cancer Treat Res; 1988; 38():149-71. PubMed ID: 2908594
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.